154 related articles for article (PubMed ID: 3859218)
1. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
Wang C; Calandra GB; Aziz MA; Brown KR
Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
[TBL] [Abstract][Full Text] [Related]
3. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients.
Calandra GB; Wang C; Aziz M; Brown KR
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():193-202. PubMed ID: 3469194
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
Shah PM
Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
[TBL] [Abstract][Full Text] [Related]
6. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
[TBL] [Abstract][Full Text] [Related]
7. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
Calandra GB; Ricci FM; Wang C; Brown KR
J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on imipenem/cilastatin sodium in pediatric field].
Nagata K; Yokoyama M; Ohnishi A; Izumi Y
Jpn J Antibiot; 1986 Jul; 39(7):1708-14. PubMed ID: 3464774
[TBL] [Abstract][Full Text] [Related]
9. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
Brooks RG; McCabe RE; Vosti KL; Remington JS
Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
[TBL] [Abstract][Full Text] [Related]
10. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections.
Cox CE; Corrado ML
Am J Med; 1985 Jun; 78(6A):92-4. PubMed ID: 3859220
[TBL] [Abstract][Full Text] [Related]
12. Imipenem/cilastatin in the treatment of osteomyelitis.
MacGregor RR; Gentry LO
Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin: general experience in a community hospital.
Iannini PB; Kunkel MJ; Hilton E; Iannini GM
Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
[TBL] [Abstract][Full Text] [Related]
14. Imipenem/cilastatin in the treatment of serious bacterial infections.
Chiodini PL; Geddes AM; Smith EG; Conlon CP; Farrell ID
Rev Infect Dis; 1985; 7 Suppl 3():S490-5. PubMed ID: 3901212
[TBL] [Abstract][Full Text] [Related]
15. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
[TBL] [Abstract][Full Text] [Related]
16. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
Garau J; Casagrán A; Sánchez C; Matas E
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
Solomkin JS; Fant WK; Rivera JO; Alexander JW
Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
Wang C; Pappas F; Cook T
Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
[TBL] [Abstract][Full Text] [Related]
20. Effect of imipenem/cilastatin on the colonic microflora.
Nord CE; Kager L; Philipson A; Stiernstedt G
Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]